PMID: 18984885

Brunham LR, Kastelein JJ, Hayden MR
ABCA1 gene mutations, HDL cholesterol levels, and risk of ischemic heart disease.
JAMA. 2008 Nov 5;300(17):1997-8; author reply 1998., [PubMed]
Sentences
No. Mutations Sentence Comment
24 ABCA1 p.Asn1800His
X
ABCA1 p.Asn1800His 18984885:24:4
status: NEW
view ABCA1 p.Asn1800His details
The N1800H mutation, although known to impair ABCA1-mediated cholesterol efflux,1,2 was associated with only a 28% reduction in HDL levels in this cohort.1 Complete loss-of-function mutations in ABCA1 tend to be associated with a 50% reduction in HDL levels, corresponding to a complete loss of function of one ABCA1 allele.3 The mild nature of these variants is again indicated by the modest impairment in efflux, especially for the rare variants, reported as 74% to 79% of normal.1 Such a small reduction in function is of questionable significance given the relatively large variability of this assay. Login to comment
25 ABCA1 p.Lys776Asn
X
ABCA1 p.Lys776Asn 18984885:25:351
status: NEW
view ABCA1 p.Lys776Asn details
In contrast, many of the pathogenic ABCA1 mutations that have been extensively characterized have less than 20% to 30% of normal efflux activity.2 These findings are also in contrast to reports from the same group on the same cohort that showed that genetic variation in ABCA1 influences IHD in the general population and, in the case of the variants K776N (in men)4 and R1587K,5 is associated with low HDL cholesterol levels. Login to comment
27 ABCA1 p.Asn1800His
X
ABCA1 p.Asn1800His 18984885:27:4
status: NEW
view ABCA1 p.Asn1800His details
The N1800H mutation, although known to impair ABCA1-mediated cholesterol efflux,1,2 was associated with only a 28% reduction in HDL levels in this cohort.1 Complete loss-of-function mutations in ABCA1 tend to be associated with a 50% reduction in HDL levels, corresponding to a complete loss of function of one ABCA1 allele.3 The mild nature of these variants is again indicated by the modest impairment in efflux, especially for the rare variants, reported as 74% to 79% of normal.1 Such a small reduction in function is of questionable significance given the relatively large variability of this assay. Login to comment
28 ABCA1 p.Lys776Asn
X
ABCA1 p.Lys776Asn 18984885:28:351
status: NEW
view ABCA1 p.Lys776Asn details
In contrast, many of the pathogenic ABCA1 mutations that have been extensively characterized have less than 20% to 30% of normal efflux activity.2 These findings are also in contrast to reports from the same group on the same cohort that showed that genetic variation in ABCA1 influences IHD in the general population and, in the case of the variants K776N (in men)4 and R1587K,5 is associated with low HDL cholesterol levels. Login to comment
54 ABCA1 p.Gly1216Val
X
ABCA1 p.Gly1216Val 18984885:54:331
status: NEW
view ABCA1 p.Gly1216Val details
ABCA1 p.Arg2144*
X
ABCA1 p.Arg2144* 18984885:54:342
status: NEW
view ABCA1 p.Arg2144* details
ABCA1 p.Pro1065Ser
X
ABCA1 p.Pro1065Ser 18984885:54:323
status: NEW
view ABCA1 p.Pro1065Ser details
Third, our findings are consistent with our previous reports on the same cohort showing that polymorphisms and mutations in ABCA1 may or may not affect HDL levels, but that risk of IHD is independent of these HDL effects.2-4 Fourth, it is not correct that to state that heterozygosity for the 3 rare mutations in the CCHS (P1065S, G1216V, or R2144X; n=6) was associated with a 25% reduction in LDL cholesterol levels compared with noncarriers because this was not statistically significant. Login to comment
61 ABCA1 p.Gly1216Val
X
ABCA1 p.Gly1216Val 18984885:61:331
status: NEW
view ABCA1 p.Gly1216Val details
ABCA1 p.Arg2144*
X
ABCA1 p.Arg2144* 18984885:61:342
status: NEW
view ABCA1 p.Arg2144* details
ABCA1 p.Pro1065Ser
X
ABCA1 p.Pro1065Ser 18984885:61:323
status: NEW
view ABCA1 p.Pro1065Ser details
Third, our findings are consistent with our previous reports on the same cohort showing that polymorphisms and mutations in ABCA1 may or may not affect HDL levels, but that risk of IHD is independent of these HDL effects.2-4 Fourth, it is not correct that to state that heterozygosity for the 3 rare mutations in the CCHS (P1065S, G1216V, or R2144X; n=6) was associated with a 25% reduction in LDL cholesterol levels compared with noncarriers because this was not statistically significant. Login to comment